GeoVax CEO to Discuss Innovative Cancer Therapies at ROTH Healthcare Conference
October 2, 2024 — GeoVax Labs, Inc. CEO to join panel on cancer therapies at ROTH Healthcare Conference. The company's lead clinical program involves a next-generation COVID-19 vaccine and a gene-directed therapy for advanced head and neck cancers.